Clinical trial
Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis…
NCT00211601 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00211601 |
|---|---|
| Title | Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041) |
| Official title | Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis |
| Acronym | C-PHONE |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chemotherapy Induced Nausea and Vomiting |
| Intervention type | Behavioral |
| Interventions | Disease Management Assessment |
| Enrollment | 1,500 |
| Start date | Aug 1, 2004 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | May 1, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: